These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4302309)

  • 1. Physicochemical characteristics of rubella antigens theta and iota.
    Le Bouvier GL
    Nature; 1969 Jan; 221(5175):78-9. PubMed ID: 4302309
    [No Abstract]   [Full Text] [Related]  

  • 2. Demonstration of rubella IgM antibody by indirect fluorescent antibody staining, sucrose density gradient centrifugation and mercaptoethanol reduction.
    Forghani B; Schmidt NJ; Lennette EH
    Intervirology; 1973; 1(1):48-59. PubMed ID: 4204098
    [No Abstract]   [Full Text] [Related]  

  • 3. Density gradient ultracentrifugation of rubella virus.
    Amstey MS; Hobbins TE; Parkman PD
    Proc Soc Exp Biol Med; 1968 Apr; 127(4):1231-6. PubMed ID: 5655671
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization of a human acute phase protein found in association with rubella virus infection.
    Cappel R; Schluederberg A; Gifford RH; Horstmann DM
    J Exp Med; 1974 Mar; 139(3):497-511. PubMed ID: 4204728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 2-mercaptoethanol on the haemagglutinating activity and antigenic properties of rubella virus.
    Ho-Terry L; Cohen A
    Arch Virol; 1981; 70(3):199-206. PubMed ID: 7325806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small size rubella virus antigens and soluble immune complexes: analysis by the platelet aggregation technique.
    Vaheri A; Vesikari T
    Arch Gesamte Virusforsch; 1971; 35(1):10-24. PubMed ID: 5002146
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on rubella virus hemagglutination. I. Activation by various treatments.
    Sato H
    Arch Gesamte Virusforsch; 1971; 35(2):256-68. PubMed ID: 5002908
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibody response in serum and nasopharynx after naturally acquired and vaccine-induced infection with rubella virus.
    Ogra PL; Kerr-Grant D; Umana G; Dzierba J; Weintraub D
    N Engl J Med; 1971 Dec; 285(24):1333-9. PubMed ID: 4107718
    [No Abstract]   [Full Text] [Related]  

  • 9. Stability of rubella complement-fixing antigens.
    Schmidt NJ; Lennette EH
    Appl Microbiol; 1967 Jul; 15(4):916-20. PubMed ID: 6049308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Density gradient centrifugation studies on rubella complement-fixing antigens.
    Schmidt NJ; Lennette EH; Dennis J
    J Immunol; 1967 Aug; 99(2):399-405. PubMed ID: 6031207
    [No Abstract]   [Full Text] [Related]  

  • 11. Some biological and immunizing properties of a high-titered freeze-dried EDTA-released rubella virus hemagglutinin containing live virus.
    Straus J
    Arch Gesamte Virusforsch; 1971; 34(2):96-104. PubMed ID: 5005508
    [No Abstract]   [Full Text] [Related]  

  • 12. [Incorporation of 3H-uridine in rubella virus particles].
    Brodersen M; Thomssen R
    Arch Gesamte Virusforsch; 1969; 26(1):118-26. PubMed ID: 5814579
    [No Abstract]   [Full Text] [Related]  

  • 13. [Removal of nonspecific inhibitors in the Rubella virus hemagglutination inhibition test employing acetone as compared to kaolin and heparin-MnCl2 pretreatment (author's transl)].
    Marklein G; Göbel U; Schäfer E
    Zentralbl Bakteriol Orig A; 1974; 229(3):290-8. PubMed ID: 4155878
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterization of trachoma antigens protective against mouse toxicity.
    Wang SP; Kenny GE; Grayston JT
    Am J Ophthalmol; 1967 May; 63(5):Suppl:1454-61. PubMed ID: 6025171
    [No Abstract]   [Full Text] [Related]  

  • 15. Physical and immunologic properties of rubella antigens.
    Schmidt NJ; Lennette EH; Gee PS; Dennis J
    J Immunol; 1968 Apr; 100(4):851-7. PubMed ID: 5645224
    [No Abstract]   [Full Text] [Related]  

  • 16. Purification of complement-fixing antigens of Rickettsia orientalis by ether extraction.
    Kobayashi Y; Nagai K; Tachibana N
    Am J Trop Med Hyg; 1969 Nov; 18(6):942-52. PubMed ID: 4311225
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of the ultracentrifuge vertical rotor in the detection of rubella-specific IgM on a sucrose density gradient.
    Luton P; Ridgway GL
    J Clin Pathol; 1979 Sep; 32(9):931-4. PubMed ID: 512054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further purification of a human placental inhibitor to hemagglutination by H-1 virus.
    Usategui-Gómez M; Morgan DF
    Proc Soc Exp Biol Med; 1968 Jan; 127(1):244-51. PubMed ID: 4296248
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison between soluble components of adenovirus types 3 and 16 and of the intermediate strain 3-16 (the San Carlos agent).
    Norrby E; Skaaret P
    Virology; 1968 Oct; 36(2):201-11. PubMed ID: 5684121
    [No Abstract]   [Full Text] [Related]  

  • 20. A simplified method for the detection of rubella-specific IgM employing sucrose density fractionation and 2-mercaptoethanol.
    Caul EO; Smyth GW; Clarke SK
    J Hyg (Lond); 1974 Dec; 73(3):329-40. PubMed ID: 4216603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.